Biosensors are now generating $13 billion in annual sales up from $5 million 30 years ago.  The combination of real-time biofeedback and the ability to deliver therapy has the promise to get us one step closer to a truly “personalized” approach to medicine.  Examples such as home glucose monitors and in-ear thermometers demonstrate that point of care biosensors can decentralize health care delivery.  Ultimately, the decentralization of health care will place patients once again at the forefront of their own care.

http://in.reuters.com/article/2012/07/19/us-science-biosensors-idINBRE86I16H20120719?mlt_click=Master+Sponsor+Logo(Active)_19_More+News_sec-col1-m1_News